Gram-Negative Pneumonia Alters Large-Vein Cell-Adhesion Molecule Profile and Potentiates Experimental Stasis Venous

Andrea T Obi1, Elizabeth Andraska, Yogendra Kanthi

  • 1Conrad Jobst Vascular Research Laboratory, University of Michigan Medical School, Ann Arbor, Mich., USA.

Abstract

Insights

Pneumonia, unlike lung contusion, elevates cell-adhesion molecules (CAMs) and increases venous thrombosis (VT) risk. This suggests CAMs are a potential target for preventing VT associated with infection.

Area of Science:

  • Immunology
  • Hematology
  • Pulmonary Medicine

Background:

  • Pneumonia is a significant risk factor for venous thrombosis (VT).
  • Cell-adhesion molecules (CAMs) are implicated in the pathogenesis of both pneumonia and VT.
  • Remote infections may create a prothrombotic state through systemic CAM elevation.

Purpose of the Study:

  • To investigate the role of cell-adhesion molecules (CAMs) in the development of venous thrombosis (VT) following pneumonia.
  • To determine if lung contusion or bacterial pneumonia induces systemic CAM elevation and prothrombotic changes.

Main Methods:

  • Induced lung injury in mice via lung contusion or Klebsiella pneumoniae inoculation.
  • Assessed circulating CAMs (P-selectin, ICAM-1, VCAM-1) and thrombin-antithrombin complexes.
  • Induced VT via inferior vena cava ligation in infected and control mice.

Main Results:

  • K. pneumoniae infection, not lung contusion, significantly increased circulating CAMs and thrombin-antithrombin complexes.
  • Pneumonia led to 3x larger VT formation compared to controls.
  • Increased vein-wall and systemic CAMs were observed in pneumonia-induced VT, with erythrocyte-rich thrombi.

Conclusions:

  • Elevated CAM expression is linked to pneumonia-induced VT, but not solely lung contusion.
  • The type of inflammatory stimulus and presence of infection drive the vein-wall response.
  • CAM elevation presents a potential therapeutic target for preventing infection-associated VT.

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
618
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.8K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
418